ClinConnect ClinConnect Logo
Search / Trial NCT05855525

Real-time fMRI for Insular Cortex Brain State-triggered Experience Sampling

Launched by DREXEL UNIVERSITY · May 3, 2023

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how our brains process experiences in real-time by using a technique called fMRI (functional Magnetic Resonance Imaging). During the study, healthy participants will take part in MRI scans while they report their thoughts and feelings based on what their brain is doing at that moment. This is done using a special system that tracks brain activity and prompts participants to share their experiences.

To join this trial, participants need to be between the ages of 18 and 35 and must not have any history of mental health or neurological disorders. They also cannot have any conditions that would make MRI scans unsafe for them. If eligible, participants can expect to spend time in an MRI machine while engaging in this unique experience-sampling activity. This research aims to better understand how our brains work when we reflect on our own thoughts and feelings, which could have implications for various areas of mental health and neuroscience.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age between 18-35
  • Exclusion Criteria:
  • History of psychiatric or neurological disorder
  • contraindication for MRI

About Drexel University

Drexel University is a prominent research institution located in Philadelphia, Pennsylvania, known for its commitment to advancing knowledge through innovative research and education. As a clinical trial sponsor, Drexel University leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical research aimed at improving health outcomes. The university fosters collaborations across various fields, including medicine, engineering, and public health, ensuring a comprehensive approach to addressing complex health challenges. With a focus on ethical standards and participant safety, Drexel University is dedicated to translating research findings into practical applications that enhance community well-being and contribute to the advancement of medical science.

Locations

Philadelphia, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

Aaron Kucyi, PhD

Principal Investigator

Drexel University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported